The NDA is based on results from REDEFINE 1, a 68-week, phase 3, randomised, double-blind, placebo-and active-controlled trial that evaluated the efficacy and safety of once-weekly, CagriSema compared to semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo, all as an adjunct to lifestyle intervention in 3,417 adults with obesity (BMI 30 kg/m2) or overweight (BMI 27 kg/m2) with one or more obesity-related complications and without diabetes, and REDEFINE 2, a double-blind, randomised, placebo-controlled, 68-week, phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus placebo, as an adjunct to lifestyle intervention in 1,206 adults with type 2 diabetes and either obesity (BMI 30 kg/m2) or overweight (BMI 27 kg/m2)
Similarly, spicy foods can irritate the esophagus and stomach, worsening the feeling of queasiness
References to evidence of weight regain after stopping treatment often reinforce this perspective, although sentiment varies widely based on personal experience, cost, and access
MOTS-c, by contrast, is not derived from hGH at all its research relevance comes from mitochondrial retrograde signaling, a communication pathway between mitochondria and the rest of the cell that governs how energy production adapts under metabolic stress